Flurazepam Capsules Shortage
Last Updated: February 18, 2025
Status: Resolved
Products Affected - Description
-
- Flurazepam capsule, Mylan (Viatris), 15 mg, bottle, 100 count, NDC 00378-4415-01 - discontinued
- Flurazepam capsule, Mylan (Viatris), 30 mg, bottle, 100 count, NDC 00378-4430-01 - discontinued
Reason for the Shortage
-
- Chartwell launched flurazepam capsules in November 2023.
- Mylan discontinued flurazepam capsules.
- Rising is planning to launch flurazepam capsules. However, the company cannot estimate a launch date.
Available Products
-
- Flurazepam capsule, Chartwell, 15 mg, bottle, 30 count, NDC 62135-0736-30
- Flurazepam capsule, Chartwell, 15 mg, bottle, 90 count, NDC 62135-0736-90
- Flurazepam capsule, Chartwell, 30 mg, bottle, 30 count, NDC 62135-0737-30
- Flurazepam capsule, Chartwell, 30 mg, bottle, 90 count, NDC 62135-0737-90
Updated
Updated February 18, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 10, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.